Sartorius Stedim Biotech (SSB) obtained exclusive global marketing and distribution rights to Aber Instruments’ single-use sensor technology for the biopharmaceutical market.
Companies aim to identify and develop therapeutics directed toward challenging disease targets
Technology will expand its mammalian and insect cell culture capacity.
Abbott has extended an agreement to market BioGenex’ Xmatrx® platform for the automation of its FISH product line. Under the terms of the agreement, BioGenex will receive a multiyear minimum volume commitment from Abbott. The...
Acquisition will significantly expand buyer's capabilities by adding research and development, formulation, lab analysis and commercial and clinical manufacturing
Factory in a box products include vaccines, oncolytic viruses, and gene and cell therapies.
Procedure uses proton beams to destroy diseased tissue for regeneration using ASCs developed in NASA-designed bioreactor.
Please wait while you are redirected to the right page...